Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Hematological profile of East African short-horn zebu calves from birth to 51 weeks of age

    This paper is the first attempt to accurately describe the hematological parameters for any African breed of cattle, by capturing the changes in these parameters over the first 12 months of an animal’s life us...

    I. Conradie van Wyk, A. Goddard, B. M. de C. Bronsvoort in Comparative Clinical Pathology (2013)

  2. No Access

    Article

    ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression

    Tumor cells adaptation to severe oxygen deprivation (hypoxia) plays a major role in tumor progression. The transcription factor HIF-1 (hypoxia-inducible factor 1), whose α-subunit is stabilized under hypoxic c...

    F Fallone, S Britton, L Nieto, B Salles, C Muller in Oncogene (2013)

  3. Article

    Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy

    Multiple myeloma (MM) is a malignancy with excessive production of monoclonal proteins. At disease presentation 30% of MM patients have significant renal impairment which may progress to renal failure requirin...

    L Kleeberg, S Morgera, C Jakob, B Hocher in European Journal of Medical Research (2009)

  4. No Access

    Article

    Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage

    Cisplatin is one of the most effectively used chemotherapeutic agents for cancer treatment. However, in humans, important cytotoxic side effects are observed including dose-limiting renal damage and profound g...

    A Rebillard, N Rioux-Leclercq, C Muller, P Bellaud, F Jouan, O Meurette in Oncogene (2008)

  5. Article

    Erratum: Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma

    Correction to: Leukemia (2008) 22, 1767–1772; doi:10.1038/leu.2008.159; published online 26 June 2008 Since the publication of their paper, the authors have identified an error in the 5-year overall survival r...

    C Jakob, J Sterz, P Liebisch, M Mieth, J Rademacher, A Goerke, U Heider in Leukemia (2008)

  6. No Access

    Article

    Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma

    Several prognostic markers, including parameters of tumor burden and cytogenetics, were adopted to identify high-risk patients in multiple myeloma (MM). Recently, the International Staging System (ISS), includ...

    C Jakob, J Sterz, P Liebisch, M Mieth, J Rademacher, A Goerke, U Heider in Leukemia (2008)

  7. Article

    Open Access

    Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis – a pilot study

    Lymphomatous meningitis (LM) represents a severe complication of malignant lymphomas. While clinical suspicion is raised by symptoms ranging from mild disturbances of sensation to severe pain or impaired consc...

    B Hildebrandt, C Müller, A Pezzutto, PT Daniel, B Dörken, C Scholz in BMC Cancer (2007)

  8. No Access

    Article

    Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

    Purpose: The purpose of this study was to compare the efficacy and toxicity of bendamustine, vincristine + prednisone (BOP) with a standard regimen of cyclophosphamide, vincristine + pred...

    M. Herold, A. Schulze, D. Niederwieser in Journal of Cancer Research and Clinical On… (2006)

  9. Article

    Open Access

    Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin

    Photochemical internalisation (PCI) is a technique for releasing biologically active macromolecules from endocytic vesicles by light activation of a photosensitiser localised in the same vesicles of targeted c...

    A Dietze, Q Peng, P K Selbo, O Kaalhus, C Müller, S Bown in British Journal of Cancer (2005)

  10. Article

    Open Access

    Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells

    Cutaneous melanoma is one of the highly malignant human tumours, due to its tendency to generate early metastases and its resistance to classical chemotherapy. We recently demonstrated that pamidronate, a nitr...

    A-M Forsea, C Müller, C Riebeling, C E Orfanos, C C Geilen in British Journal of Cancer (2004)

  11. No Access

    Article

    Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge

    C Skrabs, C Müller, H Agis, C Mannhalter, U Jäger in Leukemia (2002)

  12. No Access

    Article

    Chemotherapeutic drugs change actin skeleton organization and the expression of β-thymosins in human breast cancer cells

    Purpose: Elevated expression of the β-thymosin isotypes Tβ4, Tβ10, and T15 appears to be involved in the manifestation of a malignant phenotype of human tumor cells, including those of m...

    A. Otto, C. Müller, T. Huff, E. Hannappel in Journal of Cancer Research and Clinical On… (2002)

  13. No Access

    Article

    Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells

    The present paper summarizes the results of the second German consensus meeting on immunogenetic donor search for allotransplantation of hematopoietic stem cells held in Essen in November 1999 under the auspi...

    H. Ottinger, C. Müller, S. Goldmann, E. Albert, R. Arnold in Annals of Hematology (2001)

  14. Article

    Open Access

    Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation

    Low-dose hyper-radiosensitivity (HRS) (below 0.5 Gy) has been extensively documented in the past few years. The molecular basis of this phenomenon remains largely unknown and the purpose of this study was to i...

    S Vaganay-Juéry, C Muller, E Marangoni, B Abdulkarim in British Journal of Cancer (2000)

  15. No Access

    Article

    Transplant activities in Germany in 1998 – a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation

     To improve the infrastructure of hemopoietic stem-cell transplantations in our country, the German Registry for Hemopoietic Stem-Cell Transplantations (DRST) was established in 1998. The present paper summari...

    H. D. Ottinger, C. Müller, N. Schmitz, B. Kubanek, R. Arnold in Annals of Hematology (2000)

  16. No Access

    Article

    Acute myeloid leukemia cells with low P-glycoprotein expression and high Rhodamine 123 efflux capacity display high clonogenicity

    This study was designed to correlate the clonogenic capacity of acute myeloid leukemia (AML) cells with P-glycoprotein (P-gp) expression level and P-gp-mediated efflux capacity. Fifty AML cell samples were tes...

    C Demur, C Muller, G Cassar, C Bousquet, M Laroche, G Laurent in Leukemia (1998)

  17. No Access

    Article

    Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

    A group of 28 previously untreated patients with locally advanced or metastatic adenocarcinoma of the pancreas were entered in this phase I/II study. Treatment consisted of oral dexverapamil 1000–1200 mg/day f...

    W. Scheithauer, G. Kornek, M. Raderer in Journal of Cancer Research and Clinical On… (1995)

  18. No Access

    Chapter and Conference Paper

    Myeloperoxidase is involved in Vincristine resistance in human myeloblastic leukemia

    Horseradish peroxidase (HRP) has been shown to destroy Vincristine (VCR) by oxidation [1]. HRP is a member of the heme peroxidase family of enzymes, all of which share similar substrate specificities. Myeloper...

    D. Schlaifer, M. R. Cooper, M. Attal, A. O. Sartor in Cancer Treatment An Update (1994)

  19. No Access

    Article

    Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance

    Bridget T. Hill, L. K. Hosking, S. McClean in Journal of Cancer Research and Clinical On… (1991)

  20. No Access

    Article

    Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers

    The distribution of Gp 170, a multidrug resistance (MDR) associated glycoprotein, also called P-glycoprotein (P-gp), was examined by immunohistochemistry, using C219 and MRK16 monoclonal antibodies. Sixty-five...

    D Schlaifer, G Laurent, S Chittal, T Tsuruo, S Soues, C Muller in British Journal of Cancer (1990)

previous disabled Page of 2